Submit manuscript

Preliminary Experience of CyberKnife® Treatment of Primary Non-Small Cell Lung Cancer

Thiti Swangsilpa MD*, Pornpan Yongvithisatid MSc*, Kumutinee Pairat MSc*, Patchareporn Dechsupa MSc*, Mantana Dhanachai MD*, Somjai Dangprasert MD*, Ladawan Narkwong MD*, Chomporn Sitathanee MD*, Putipun Puataweepong MD*, Parmon Puddhikarant MD*, Chuleeporn Jiarpinitnun MD*, Patamintita Witoonpanich MD*, Taweesak Ukhumpun BSc*, Juthamat Khaophong BSc*

Affiliation : * Radiation Oncology Division, Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand


Objective : Provide the effectiveness of treatment protocol, radiotherapy plan, technique, and early clinical results of inoperable primary non-small cell lung cancer (NSCLC) in patients who received CyberKnife® treatment at Ramathibodi Hospital. Material and Method: Six cases of inoperable primary NSCLC patients were evaluated for tumor response after having received CyberKnife® treatment. The prescribed radiation dose was 45 gray (Gy) in three consecutive fractions for peripherally located tumor and 50 Gy in five fractions within two weeks for centrally located tumor (biological equivalent dose, BED, 112.5 Gy10, and 100 Gy10, respectively). The response to treatment was evaluated from roentgenographic study during follow-up period along with clinical outcome and adverse event.
Results : Overall response after the treatment was demonstrated in five cases with roentgenographic complete response (CR, disappearance of tumor) and partial response (PR, 50% decrease in size) in two and three cases, respectively without any severe adverse event. The treatment planning parameters demonstrated the effectiveness of radiation dose homogeneity and conformity coverage of the target volume.
Conclusion : This preliminary report has provided the effectiveness of treatment plan and local tumor controlled without severe adverse event for primary inoperable NSCLC patients receiving CyberKnife® treatment.

Keywords : CyberKnife®, Stereotactic body radiotherapy, Non-small cell lung cancer


All Articles Download


INFORMATION

Contact info

JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com

JMed Assoc Thai
MEDICAL ASSOCIATION OF THAILAND
ISSN: 0125-2208 (Print),
ISSN: 2408-1981 (Online)
The content of this site is intended for health professionals.

Submissions

» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement

Other

» Journal Sponsorship » Site Map » About this Publishing System

© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.